(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Terapia génica del cáncer > DA - CIMA - Terapia génica y Hepatología - Terapia génica del cáncer - Artículos de revista >

Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction
Autor(es) : Berraondo, P. (Pedro)
Crettaz, J. (Julien)
Ochoa, L. (Laura)
Pañeda, A. (Astrid)
Prieto, J. (Jesús)
Troconiz, I.F. (Iñaki F.)
Gonzalez-Aseguinolaza, G. (Gloria)
Palabras clave : Dependovirus/genetics
Gene Therapy/methods
Liver/virology
Recombinant Proteins/genetics
Fecha incorporación: 2006
Editorial : Mary Ann Liebert
Versión del editor: http://online.liebertpub.com/doi/abs/10.1089/hum.2006.17.601
ISSN: 1557-7422
Cita: Berraondo P, Crettaz J, Ochoa L, Paneda A, Prieto J, Troconiz IF, et al. Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction. Hum Gene Ther 2006 Jun;17(6):601-610.
Resumen
The liver is an attractive organ for gene therapy because of its important role in many inherited and acquired diseases. Recombinant adeno-associated viruses (rAAVs) have been shown to be good candidates for liver gene delivery, leading to long-term gene expression. We evaluated the influence of the route of administration on rAAV-mediated liver transduction by comparing levels of luciferase expression in the livers of male and female mice after injection of rAAV serotype 2, using three different routes of administration: intravenous (IV), intraportal (IP), or direct intrahepatic (IH) injection. To determine transgene expression we used a noninvasive optical bioluminescence imaging system that allowed long-term in vivo analysis. After IV injection dramatic differences in liver transgene expression were observed, depending on gender. When IP injection was used the differences were reduced although they were still significant. Interestingly, direct intrahepatic injection of rAAV vectors was associated with the fastest and strongest onset of luciferase expression. Moreover, no gender differences in liver transduction were observed and luciferase expression was confined to the site of injection. Thus, direct intrahepatic injection of rAAV offers specific advantages, which support the potential of this route of administration for future clinical applications.
Enlace permanente: http://hdl.handle.net/10171/23325
Aparece en las colecciones: DA - Farmacia - Tecnología Farmacéutica - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Terapia génica del cáncer - Artículos de revista

Ficheros en este registro:
Fichero:  HumanGeneTherap2006_17_601.pdf
Descripción: 
Tamaño:  3,96 MB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.